Chronological chart 2004 - Diagnostic approach to breast disease;"Charta senologica 2004": Approccio diagnostico alla patologia mammaria

Radiologia Medica

Volumn 108, Issue 5-6, 2004, Pages 569-587

  Di Maggio, C ^a   Del Favero, C ^a   Frigerio, A ^a   Giuseppetti, G M ^a   Gozzi, G ^a   Lattanzio, E ^a   Pesce, B ^a   Rosselli Del Turco, M ^a   Simonetti, G ^a   Nosenzo, M A ^a   Bazzocchi, M ^a   Del Maschio, A ^a   Gandini, G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BREAST DISEASE; BREAST EXAMINATION; CONFERENCE PAPER; CYTOLOGY; DIAGNOSTIC IMAGING; HUMAN; INFORMED CONSENT; MAMMOGRAPHY; MODEL; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PSEUDOCYSTIGRAPHY; RADIATION ATTENUATION; RADIOGRAPHY; SCINTIMAMMOGRAPHY; SCREENING TEST;

ADULT; AGE FACTORS; AGED; BIOPSY, NEEDLE; BREAST; BREAST DISEASES; BREAST NEOPLASMS; CONSENSUS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; RISK FACTORS; SELF-EXAMINATION; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, DOPPLER, COLOR; ULTRASONOGRAPHY, MAMMARY;

EID: 19944432388     PISSN: 00338362     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (111)

1. Hackshaw AK, Paul EA: Breast self-examination and death from breast cancer: a meta-analysis. Br J Cancer 88: 1047-1053, 2003.
2. Weiss NS: Breast cancer mortality in relation to clinical breast examination and breast self-examination. Breast J 9: 86-89, 2003.
3. Lamarque JL, Cherifcheikh J, Laurent JC et al: La qualité en mastologie: critères, contrôle. Manosmed, Tome I, Montpellier: Sauramps médical, 1997
4. Cuzick J. Epidemiology of breast cancer - selected highlights. Breast 12: 405-411, 2003.
5. Kolb ThM, Lichy J, Newhouse JH. Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factor that influence them: an analysis of 27,825 patient evaluations. Radiology 225: 165-175, 2002.
6. Berlin L: The missed breast cancer redux: time for educating the public about the limitation of mammography? AJR 176: 1131-1134, 2001.
7. Controllo di qualità in mammografia: aspetti tecnici e clinici. Istituto superiore di sanità. ISTISAN 95/12 (ISSN 1123-3117), Roma, 1995.
8. European guidelines for quality assurance in mammography screening. Terza edizione. EUREF, Gennaio 2001.
9. Hendrick RE, Basset L, Bosco MA et al: Mammography quality control manual. Reston, Va: American College of Radiology, 1999.
10. Perry NM (EUSOMA Working Party): Quality assurance in the diagnosis of breast disease. Eur J Cancer 37: 159-172, 2001.
11. Cole EB, Pisano ED, Kistner EO et al: Diagnostic accuracy of digital mammography in patients with dense breast. Radiology 226: 153-160, 2003.
12. Gambaccini M, Baldelli P. Mammografia digitale. Principi fisici e sviluppi futuri. Radiol Med 106: 454-466, 2003.
13. Gennaro G, Baldelli P, Taibi A et al: Patient dose in full-field digital mammography: an Italian survey. Eur Radiol 14: 645-652, 2004.
14. James JJ: The current status of digital mammography. Clin Radiol 59: 1-10, 2004.
15. Baker JA, Rosen EL, Lo JY et al: Computer-aided detection (CAD) in screening mammography. AJR 181: 1083-1088, 2003.
16. Brem RF, Baun J, Lechner M et al: Improvement in sensitivity of screening mammography with computer-aided detection: a multi-institutional trial. AJR 181: 687-693, 2003.
17. Ciatto S, Rosselli Del Turco M, Burke P et al: Comparison of standard and double reading and computer-aided detection (CAD) of interval cancers at prior negative screening mammograms: blind review. Br J Cancer 89: 1645-1649, 2003.
18. Stines J, Noel A, Levy L et al: Digital mammography and computer assisted diagnosis. J Radiol 83: 581-590, 2002.
19. Gregg EC: Radiation risks with diagnostic x-rays. Radiology 123: 447-453, 1977.
20. Feig SA: Can breast cancer be radiation induced? In: Logan WW, (ed). Breast carcinoma, pp. 5-14. Wilev Med Pub, New York, 1977.
21. Dendy PP, Brugmans MJP: Low dose radiation risks. Br J Radiol 76: 674-677, 2003.
22. Law J, Faulkner K: Concerning the relationship between benefit and radiation risk, and cancers detected and induced, in a breast screening programme. Br J Radiol 75: 678-684, 2002.
23. Sharan SK, Morimatsu M, Albrecht U et al: Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature 386: 804-810, 1997.
24. Tavassoli FA, Devilee P: Pathology and Genetics of tumours of the Breast and Femal Genital Organs. IARC (Int. Agency for Research on Cancer) - WHO - OMS. Lyon, IARC Press 2003.
25. Amici F, Baldassarre S, Giuseppetti GM: Imaging in senologia. Testo Atlante. Milano: Poletto Ed, 2000.
26. American College of Radiology. Illustrated Breast Imaging Reporting And Data System (BI-RADS) The Fourth Edition. Reston (VA) ACR 2003.
27. ANAES (Agence National d'Accreditation e d'Evaluation de la Santè) Recommandations pour la pratique clinique. Synthèse des recommandations cancer du sein 1998. Paris: ANAES 1998.
28. Lattanzio V, Simonetti G: Mammografia: guida alla refertazione ed alla codifica dei risultati ReCoRM. Napoli: Idelson-Gnocchi srl 2002.
29. Burrel HC, Pinder SE et al: The positive predictive value of mammographic signs. Clin Radiol 51: 277-281, 1996.
30. Tabar L, Dean PB: Atlante Diagnostico di Mammografia. 2° Ed. UTET, Torino, 2002.
31. Fileni A, Magnavita N: Denunce contro radiologi in Italia. Radiol Med 99: 182-187, 2000.
32. Guthrie TH. Breast cancer litigation: an update with practice guidelines. Breast J 335-339, 1999.
33. Kopans DB: Mammography screening is saving thousands of lives, but will it survive medical malpractice? Radiology 230: 20-24, 2004.
34. Buccelli C, De Ferrari F, Smaltino F et al: Radiologia Forense. Mediserve Srl Milano 2000.
35. Giuseppetti GM: L'ecografia senologica. Radiol Med 104: 1-12, 2002.
36. Merritt CRB: Technology update. Radiol Clin North Am 39: 385-397, 2001.
37. Rizzatto G: Towards a more sophisticated use of breast ultrasound. Eur Radiol 11: 2425-2435, 2001.
38. Jakobsen JA: Ultrasound contrast agents: clinical application. Eur Radiol 11: 1329-1337, 2001.
39. Martinez AM, Medina CJ, Bustos C et al: Assessment of breast lesions using Doppler with contrast agents. Eur J Gynaecol Oncol 24: 527-30, 2003.
40. Kaplan SS: Clinical utility of bilateral whole-breast US in the evaluation of women with dense breast tissue. Radiology 221: 641-649, 2001.
41. Kolb Th, Lichy J, Newhouse JH: Occult cancer in women with dense breast: normal mammographic and physical examination findings: detection with screening US. Radiology 207: 191-199, 1998.
42. Moy L, Slanertz P, Moore MA et al: Specificity of mammography and ultrasound in the evaluation of a palpable abnormality: retrospective review. Radiology 225: 176-181, 2002.
43. Zonderland HM, Coerkamp EG, Hermans J et al: Diagnosis of breast cancer: contribution of US as an adjunct to mammography. Radiology 213: 413-422, 1999.
44. Balu-Maestro C, Chapellier C, Bleuse A: Place de l'échographie dans le dépistage du cancer du sein. J Le Sein 13: 127-134, 2003.
45. Feig SA: Breast masses: mammographic and sonographic evaluation. Radiol Clin North Am 30: 67-94, 1992.
46. Kopans DB. Sonography should not be used for breast cancer screening until its efficacy has been proven scientifically. AJR 182:489-91, 2004.
47. American College of Radiology. ACR standard for performance of the breast ultrasound examination. In: Standards American College of Radiology (20002001): 389-392.
48. Del Maschio A, De Gaspari A, Panizza P: Risonanza Magnetica in senologia. Radiol Med 104: 253-261, 2002.
49. Morris EA: Breast cancer imaging with MR. Radiol Clin North Am 40: 349-355, 2002.
50. Teifke A, Lehr HA, Vomweg TW et al: Outcome analysis and rational management of enhancing lesions incidentally detected on contrast-enhanced MRI of the breast. AJR 181: 655-662, 2003.
51. Baum F, Fischer U, Vosshenrich R et al: Classification of hypervascularized lesions in CE MR imaging of the breast. Eur Radiol 12: 1087-1092, 2002.
52. Kuhl CK, Schmutzer RK, Leutner C et al: Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancers susceptibility gene: preliminary results. Radiology 215: 267-279, 2000.
53. Podo F, Sardanelli F, Canese R et al: The Italian Multi-Centre Project on evaluation of MRI and other imaging modalities in early detection of mammary tumors in subjects at high genetic risk. J Exp Clin Cancer Res 21/3: 115-124, 2002.
54. Tilanus-Linthorst MM, Obdeijn IM, Bartels KC et al: First experience in screening women at high risk for breast cancer with MR imaging. Breast Cancer Res Treat 63: 53-60, 2000.
55. Schorn C, Fischer U, Luftner-Nagel S et al: MRI of the breast in patients with metastatic disease of unknown primary. Eur Radiol 9: 470-473, 1999.
56. Fischer U, Kopka L, Grabbe E: Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology 213: 881-888, 1999.
57. Oellinger H, Heins S, Sander B et al: Gd-DTPA enhanced MRI of breast: the most sensitive method for detecting multicentric carcinomas in female breast? Eur Radiol 3: 223-226, 1993.
58. Slanetz PJ, Edmister WB, Weisskoff RM et al: Occult contralateral breast cancer detected by breast MR. Radiology 209: 416, 1998.
59. Panizza P, De Gaspari A, Vanzulli A et al: Role of MR Mammography (MRM) in planning preoperative chemotherapy treatment and analyzing results. Eur Radiol 7: 242, 1997.
60. Wasser K, Sinn HP, Fink C et al: Accuracy of tumor size measurement in breast cancer using MRI is influenced by histological regression induced by neoadjuvant chemotherapy. Eur Radiol 6: 1213-1223, 2003.
61. Dao TH, Rahmouni A, Campana F et al: Tumor recurrences versus fibrosis in the irradiated breast: differentiation with dinamic gadolinium enhancement MR imaging. Radiology 187: 751-755, 1993.
62. Solomon B, Orel SG, Reynolds C et al: Delayed development of enhancement in fat necrosis after breast conservation therapy: a potential pitfall of MR imaging of the breast. AJR 170: 966-968, 1998.
63. Ahn CY, Shaw WW, Narayanan K et al: Definitive diagnosis of breast implant rupture using magnetic resonance imaging. Plast Reconstr Surg 94: 681-691, 1993.
64. Gorzica DC, De Bruhl ND, Mund DF et al: Linguine sign at MR imaging it represent collapse silicone implant shell? Radiology 191: 576-577, 1994.
65. Reynolds HE, Buckwalter KA, Jackson VP et al: Comparison of mammography, sonography, and magnetic resonance imaging in the detection of silicone-gel breast implant rupture. Ann Plast Surg 33: 247-257, 1994.
66. Liberman L, Morris EA, Dershaw DD et al: Fast MRI-Guided Vacuum assisted breast biopsy: Initial Experience. AJR 181: 1283-1293, 2003.
67. Panizza P, De Cobelli F, De Gaspari A et al: MR-guided stereotactic breast biopsy: technical aspects and preliminary results. Radiol Med 106: 232-244, 2003.
68. Viehweg P, Heinig A, Amaya B et al: MR-guided interventional breast procedures considering vacuum biopsy in particular. Eur Radiol 42: 32-39, 2002.
69. Taylor A, Schuster DM, Alazraki N: Medicina nucleare. Ed. Minerva Medica, Torino 2003.
70. Bombardieri E, Crippa F: PET imaging in breast cancer. Q J Nucl Med 45: 245-256, 2001.
71. Pisano ED, Fajardo LL, Tsinikas I et al: Rate of insufficient samples for fine needle aspiration for non palpable breast lesions in a multicenter Clinical Trial. Cancer 82: 679-688, 1998.
72. Helbich TH, Matzek W, Fuchsjager MH: Stereotactic and ultrasound-guided breast biopsy Eur Radiol 2003; Published online 13 novembre 2003.
73. Pisano ED, Fajardio LL, Caudry DJ et al: Fine-Needle Aspiration Biopsy of nonpalpable lesions in a multicenter Clinical trial. Radiology 219: 785-792, 2001.
74. Sauer T, Myrvold K, Lomo J et al: Fine-needle aspiration cytology in non-palpable mammographic abnormalities in breast cancer screening. Breast 12: 314-319, 2003.
75. Jackman RJ, Burbank F, Parker SH et al: Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation rates. Radiology 218: 497-502, 2001.
76. Deurloo EE, Tanis PJ, Gilhuijs KG et al: Reduction in the number of sentinel lymph node procedures by preoperative ultrasonography of the axilla in breast cancer. Europ J Canc 39: 1068-1073, 2003.
77. Di Maggio C, La Grassa M, Pescarini L et al: Indicazioni al prelievo con ago ed alla scelta metodologica. In: Nori J, Bazzocchi M (eds). Senologia. Stato dell'arte in interventistica, pp. 33-41. Napoli: Idelson-Gnocchi 2003.
78. Nori J, Bazzocchi M: Senologia. Stato dell'arte in interventistica. Napoli: Idelson-Gnocchi, 2003.
79. Parker SH, Klaus AJ, Schilling KJ, et al: Sonographically guided directional vacuum-assisted breast biopsy using a handled device. AJR 177: 405-408, 2001.
80. Boyd NF, Byng JW, Jong RA: Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Natl Cancer Inst 87: 670-675, 1995.
81. Boyd NF, Dite GS, Stone J et al: Heritability of mammographic density, a risk factor for breast cancer. N Engl J Med 347: 886-894, 2002.
82. Harvey JA, Bovbierg VE: Quantitative assessment of mammographic breast density: relationship with breast cancer risk. Radiology 230: 29-41, 2004.
83. Mandelson MT, Oestreicher N, Porter PL et al: Breast density as a predictor of mammographic detection: comparison of interval and screen-detected cancers. J Natl Cancer Inst 92: 1081-1087, 2000.
84. Di Maggio C: Il serviziodi senologia diagnostica. Radiol Med 81: 585-591, 1991.
85. Bjurstam N, Bjorneld L, Duffy SW et al: The Gothenburg Breast Screening Trial. First results on mortality, incidence and mode of detection for women aged 39-49 years at randomization. Cancer 80: 2091-2099, 1997.
86. Duffy SW, Tabar L, Chen HH et al: The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish Counties . Cancer 95: 458-469, 2002.
87. Nystrom L, Andersson I, Bjurstam N et al: Long term effects of mammography screening: uptated overview of the Swedish randomised trials. Lancet 359: 909-919, 2002.
88. Peto R et al: UK and USA breast cancer deaths down 25% in year 2000 ad ages 20-69 years (letter). Lancet 20: 1822, 2000.
89. Vanara F, Ponti A, Frigerio A et al: Analisi dei costi di un programma di screening mammografico. Epidemiologia e prevenzione 19: 318-329, 1995.
90. Sickles EA, Wolverton DE, Dee KE: Performance parameters for screening and diagnostic mammography: specialist and general radiologists. Radiology 224: 861-869, 2002.
91. Di Maggio C, Giuseppetti G, Gozzi G et al. La mammografia nelle quarantenni: verso un chiarimento definitivo. Radiol Med 87: 731-735, 1994.
92. Fletcher SW, Elmore JG: Mammographic screening for breast cancer. N Engl J Med 348: 1672-1680, 2003.
93. Wald NJ, Chamberlain J, Hackshav A: Report of the European Society for mastology on Breast Cancer Screening. Breast 2: 209-216, 1993.
94. Advisory Committee on Cancer Prevention: Recommendations on cancer screening in the European Union. Europ J Cancer 36: 1473-1478, 2000.
95. American Cancer Society: Guidelines for clinical cancer prevention. 1999-2003.
96. Piscioli F, Cristofolini M: Modelli operativi di prevenzione secondaria del carcinoma della mammella. Trento: Tipolitografia Temi, 1996.
97. Rosselli Del Turco M: Programmi di screening per il carcinoma mammario. In: Veronesi U et al, eds. Senologia oncologica, pp. 165-176. Milano: Masson Ed, 1999.
98. Maijd AS, Shaw De Paredes E, Doherty RD et al: Missed breast carcinoma: pitfalls and pearl. Radiographics 23: 881-895, 2003.
99. Marra V, Frigerio A, Di Virgilio MR et al: Il carcinoma mammario diagnosticato nello screening mammografico nei passaggi di incidenza. Radiol Med 98: 342-346, 1999.
100. Raja MA, Hubbard A et al: Interval breast cancer: is it a different type of breast cancer? Breast 10: 100-108, 2001.
101. Zappa M, Falini P, Bonardi D et al: Monitoring interval cancers in mammographic screening: the Florence District programme experience. Breast 11: 301-305, 2002.
102. Bauce A, Benesso S, Galiano A: Relazione tra densità mammografica, età delle pazienti e sensibilità. Radiol Med 5 suppl. 1: 271, 1998.
103. Feig SA: Increased Benefit from shorter screening mammography intervals for women ages 40-49 years. Cancer 80: 2035-2039, 1997.
104. Michaelson JS, Halpern E, Kopans DB: Breast cancer computer simulation method for estimation of optimal intervals for screening. Radiology 212: 551-560, 1999.
105. Rosen EL, Baker JA, Soo MS: Malignant lesions initially subjected to short-term mammographic follow-up. Radiology 223: 221-228, 2002.
106. Bancej C, Decker K, Chiarelli A et al: Contribution of clinical breast examination to mammography screening in the early detection of breast cancer. J Med Screen 10: 16-21, 2003.
107. Consiglio dell'Unione Europea. Raccomandazioni del 2-12-2003 sullo screening dei tumori. 2003/878/CE G.U. Unione Europea 16.12.2003 L 327/34-37.
108. Smart CR, Hendrick RE, Rutledge JH et al: Benefit of mammography screening in women ages 40 to 49 years. Cancer 75: 1619-1626, 1995.
109. Dilhuydy MH, Monnereau A, Barreau B: Le dépistage "à la française". Action programmée ou aménagement du diagnostic précoce individuel? J Le Sein 2: 83-90, 2003.
110. Di Maggio C, Fioretti P, La Grassa M et al: Screening mammografico o diagnostica clinica? Proposta di un modello unificato. Radiol Med 101: 326-333, 2001.
111. Rosselli Del Turco M, Zappa M: Osservatorio Nazionale per la prevenzione dei tumori femminili. Secondo rapporto. ABC Tipografica di Sesto Fiorentino (FI) 2003.